Growth Metrics

Biogen (BIIB) Retained Earnings (2016 - 2026)

Biogen has reported Retained Earnings over the past 18 years, most recently at -$140.2 million for Q1 2026.

  • For Q1 2026, Retained Earnings fell 100.72% year-over-year to -$140.2 million; the TTM value through Mar 2026 reached -$140.2 million, down 100.72%, while the annual FY2025 figure was $20.6 billion, 6.71% up from the prior year.
  • Retained Earnings for Q1 2026 was -$140.2 million at Biogen, down from $20.6 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $20.6 billion in Q4 2025 and troughed at -$214.8 million in Q3 2025.
  • A 5-year average of $6.7 billion and a median of -$140.2 million in 2026 define the central range for Retained Earnings.
  • On a YoY basis, Retained Earnings climbed as much as 13891.16% in 2025 and fell as far as 101.13% in 2025.
  • Year by year, Retained Earnings stood at -$164.9 million in 2022, then skyrocketed by 10789.87% to $17.6 billion in 2023, then rose by 9.26% to $19.3 billion in 2024, then grew by 6.71% to $20.6 billion in 2025, then tumbled by 100.68% to -$140.2 million in 2026.
  • Business Quant data shows Retained Earnings for BIIB at -$140.2 million in Q1 2026, $20.6 billion in Q4 2025, and -$214.8 million in Q3 2025.